In the JournalsPerspective

Cyclosporine-chondroitin improves dry eye signs, symptoms in ongoing trial

August 13, 2019
Preliminary study results show significant improvement in dry eye questionnaire scores, subjective symptoms and corneal staining in patients with…

Meeting News

Tivanisiran improves discomfort, hyperemia in patients with dry eye

August 2, 2019
VANCOUVER, British Columbia – Results from phase 2 and phase 3 trials showed that tivanisiran 1.125% significantly improved ocular…

In the JournalsPerspective

DNase drops show promise in reducing dry eye symptoms

July 18, 2019
Recombinant deoxyribonuclease eye drops show potential in reducing both the signs and severity of dry eye in patients with severe tear-deficient dry…

In the JournalsPerspective

Gel eye drops containing hrDecorin reduce corneal scarring from keratitis

July 15, 2019
Researchers have shown that a novel eye drop can be used as a method of sustained delivery of antifibrotic drugs in patients with fibrosis associated…

Perspectives on GlaucomaPerspective

New hypotensive agent shows good results in phase 2 studies

April 30, 2019
A new hypotensive agent that could potentially enrich the armamentarium of glaucoma medications showed efficacy and safety in phase 2 trials. …

Perspectives on GlaucomaPerspective

Trial supports SLT as first-line treatment for glaucoma, ocular hypertension

April 26, 2019
In a large 3-year trial, selective laser trabeculoplasty showed better control of IOP and better cost-effectiveness than eye drops as a first-line…

PCON Reports

Experts say future of glaucoma treatment may lie in sustained release

Primary Care Optometry News, April 2019
“As we are able to diagnose glaucoma earlier and earlier and have a better understanding of the disease, it will help to determine the most…

BLOG: Why does hydroxychloroquine retinopathy look like a bull’s eye?

April 11, 2019
Much has been written about screening for hydroxychloroquine toxicity. In 2016 there was a major paper from the American Academy of Ophthalmology…

Perspectives on GlaucomaPerspective

More IOP fluctuations found in medically than surgically treated eyes

April 2, 2019
Nocturnal IOP-related fluctuations are significantly more pronounced in medically treated than in surgically treated glaucoma, according to a study. …

Novartis spinoff of Alcon expected April 9

March 28, 2019
Novartis announced that its spinoff of Alcon is expected to be completed April 9. Certain conditions necessary for the 100% spinoff to occur have…

In the JournalsPerspective

Antihistamine delivery via contact lens shown to be effective

March 27, 2019
A study published in Cornea showed that the ocular antihistamine ketotifen was effectively delivered via a contact lens also designed for visual…

In the JournalsPerspective

Treatment may not be necessary in children with intermittent exotropia

March 26, 2019
Children 3 to 10 years old with intermittent exotropia are not likely to progress to constant exotropia and may improve spontaneously over 3 years…

Meeting NewsVideo

VIDEO: New brand of loteprednol has increased penetration

March 22, 2019
NEW YORK – Marc Bloomenstein, OD, said he uses Kala’s new Inveltys (loteprednol etabonate ophthalmic suspension 1%) in both cataract and…

Meeting News

New drug delivery technologies may improve compliance in glaucoma patients

March 20, 2019
NEW ORLEANS – New drug delivery technologies will assist clinicians in treating noncompliant glaucoma patients, Ike K. Ahmed, MD

At Issue

Panelists choose both branded, compounded agents for cataract surgery patients

Primary Care Optometry News, March 2019
Maynard L. Pohl, OD, FAAO: My personal clinical mission in the perioperative care I provide is to strive for excellence in helping to meet each…

Meeting News

Glaucoma expert endorses ‘interventional glaucoma’ treatment

March 12, 2019
NEW ORLEANS – It is time to change the glaucoma treatment paradigm, Ike K. Ahmed, MD, said here at SECO. The opportunity is now for disruption…

Meeting News

New drugs, delivery methods in the pipeline for ocular surface, retina, glaucoma

March 8, 2019
NEW ORLEANS – A multitude of treatments options in development for the ocular surface, retina and glaucoma have the potential to greatly…

Meeting News

Payment issues may restrict access to new glaucoma treatments

March 6, 2019
NEW ORLEANS – A panel here at the Ophthalmic Innovation Summit, held during SECO, recognized the dramatic advances made in the field of…

Meeting News

Industry leaders recognize strong influence of optometric practices

February 22, 2019
NEW ORLEANS – Participants on an industry panel here at the Ophthalmic Innovation Summit held during SECO agreed that optometry’s…

New therapeutics, technologies help clinicians fight dry eye

Primary Care Optometry News, February 2019
Jacob Lang, OD, FAAO, Dipl ABO; Nicole Harris
Optometrists have the opportunity to be “heroes” by using knowledge and technology to combat surface inflammation, loss of homeostasis…